We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Industry

Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Waters Corporation and Quest Diagnostics have formed a collaboration to broaden access to the FDA-cleared Onclarity Self-Collection Kit. More...
22 Oct 2026
Image: AlzoSure Predict is designed to help clinicians assess the likelihood of Alzheimer’s disease progression in patients with mild cognitive impairment. (Photo courtesy of Diadem)

Alzheimer’s Progression Blood Test Gains U.S. Patent Ahead of Planned Launch

A new blood test predicts Alzheimer’s progression up to six years before symptoms by measuring a disease-related protein marker. More...
22 Oct 2026
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic has signed a definitive agreement to acquire precision oncology company Reveal Genomics. More...
20 Oct 2026
Image: The definitive agreement covers Myriad Genetics’ Prenatal Health testing business, including the Prequel, Foresight, SneakPeek, and FirstGene tests. (Photo courtesy of Myriad Genetics)

Myriad Genetics to Sell Prenatal Testing Portfolio to Labcorp

Myriad Genetics has entered into a definitive agreement to sell its Prenatal Health testing business to Labcorp for $210 million. More...
20 Oct 2026
Image Credit: iStock

Managed Care Report Examines Barriers to Breast Cancer Biomarker Testing

A new analysis examines uncertainty around biomarker testing and managed care for advanced breast cancer with ESR1 mutations. More...
20 Oct 2026
Image: Latest trends show that cancer diagnosis is evolving beyond a process focused mainly on medical imaging and microscopic tissue examination toward a more layered approach that incorporates molecular and genomic testing, liquid biopsy, digital pathology, and AI (Image Credit: iStock)

Expanding Screening and Biomarker Testing Drive Cancer Diagnostics Market Growth

New data forecast the cancer diagnostics market to reach USD 41.5B by 2031 at 7.2% CAGR amid growth in IVDs and liquid biopsy More...
20 Oct 2026
Image: The MyChoice CDx test, currently used as a companion diagnostic in ovarian cancer, will generate the PrGIS score and is being advanced for use in prostate cancer. (Photo courtesy of Myriad Genetics)

Collaboration Advances Genomic Instability Biomarker for Prostate Cancer

A new collaboration aims to advance a prostate cancer genomic instability score for clinical trials and companion diagnostics. More...
20 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Gastrointestinal Panel
Xpert® GI Panel
Gold Member
Neonatal Heel Incision Device
Tenderfoot


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2026 Globetech Media. All rights reserved.